In addition, we identified a tumorigenic signature of 493 differentially expressed genes comprising the overlap of two enriched tumor-initiating cell populations (CD44+/CD24−/low vs. bulk tumor cells and mammospheres vs. primary tumor) using biopsies obtained from women with primary breast cancer [2]. The gene discussed is CD44; the disease is breast cancer.